Last update 21 Nov 2024
OPB-111001
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with OPB-111001A Two-part Phase 1/2a, Open-label, Dose Escalation Study to Evaluate the Tolerability and Preliminary Antitumour Activity of OPB-111001 in Patients With Advanced Cancers That Are Poorly Responsive to Standard Anticancer Treatment
100 Clinical Results associated with OPB-111001
Login to view more data
100 Translational Medicine associated with OPB-111001
Login to view more data
100 Patents (Medical) associated with OPB-111001
Login to view more data
100 Deals associated with OPB-111001
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced cancer | Phase 2 | GB | 01 Jan 2014 | |
| Breast Cancer | Phase 2 | GB | 01 Jan 2014 | |
| Cervical Squamous Cell Carcinoma | Phase 2 | GB | 01 Jan 2014 | |
| Endometrial Carcinoma | Phase 2 | GB | 01 Jan 2014 | |
| Ovarian Cancer | Phase 2 | GB | 01 Jan 2014 | |
| Prostatic Cancer | Phase 2 | GB | 01 Jan 2014 | |
| Salivary Gland Neoplasms | Phase 2 | GB | 01 Jan 2014 | |
| Squamous Cell Carcinoma | Phase 2 | GB | 01 Jan 2014 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free